|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
13
|
|
pubmed:dateCreated |
2007-5-1
|
|
pubmed:abstractText |
Panitumumab is a fully human monoclonal antibody directed against the epidermal growth factor receptor (EGFR). We compared the activity of panitumumab plus best supportive care (BSC) to that of BSC alone in patients with metastatic colorectal cancer who had progressed after standard chemotherapy.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1527-7755
|
|
pubmed:author |
pubmed-author:AmadoRafael GRG,
pubmed-author:CanonJean-LucJL,
pubmed-author:HendliszAlainA,
pubmed-author:HumbletYvesY,
pubmed-author:MaurelJoanJ,
pubmed-author:NeynsBartB,
pubmed-author:PeetersMarcM,
pubmed-author:RichardsonGaryG,
pubmed-author:SienaSalvatoreS,
pubmed-author:Van CutsemEricE,
pubmed-author:Van LaethemJean-LucJL,
pubmed-author:WolfMichaelM
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
1
|
|
pubmed:volume |
25
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1658-64
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:17470858-Aged,
pubmed-meshheading:17470858-Antibodies, Monoclonal,
pubmed-meshheading:17470858-Antineoplastic Agents,
pubmed-meshheading:17470858-Colorectal Neoplasms,
pubmed-meshheading:17470858-Disease-Free Survival,
pubmed-meshheading:17470858-Female,
pubmed-meshheading:17470858-Humans,
pubmed-meshheading:17470858-Immunohistochemistry,
pubmed-meshheading:17470858-Male,
pubmed-meshheading:17470858-Middle Aged,
pubmed-meshheading:17470858-Neoplasm Metastasis,
pubmed-meshheading:17470858-Receptor, Epidermal Growth Factor
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer.
|
|
pubmed:affiliation |
Digestive Oncology Unit, University Hospital Gasthuisberg, Leuven, Belgium. eric.vancutsem@uz.kuleuven.ac.be
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Clinical Trial, Phase III
|
